Post-market skin care for after full-face laser treatment with Ariessence Pure PDGF+
Official title: A Multi-center, Post-market Cosmetic Evaluation of Ariessence™ Pure PDGF+ Following Ablative Laser for the Tolerability and Improvement in the Appearance of Aging Skin.
Run by Lynch Regenerative Medicine · NCT07718347 · Data updated 2026-11-12
This post-market study tests whether applying Ariessence Pure PDGF+ after an ablative laser helps people feel more comfortable and improves skin appearance compared to a standard emollient.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 70 Years |
| Sex | All |
| Enrollment | 21 (estimated) |
| Sponsor | Lynch Regenerative Medicine Research network |
| Locations | 2 sites (Sacramento, California and 1 other locations) |
| Status | Recruiting |
| Started | April 16, 2026 |
| Main results expected | November 2026 |
| Study ends | February 2027 |
| Registry record updated | July 21, 2026 |
| Trial ID | NCT07718347 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40-65 with Glogau III-IV aging skin, Fitzpatrick II-IV, suitable for ablative laser, non-smokers for at least 3 years, and willing to follow post-procedure care with documentation.
✕Probably not a fit
Patients outside the age range, with Fitzpatrick I or > IV, active skin disease, recent facial procedures, or pregnancy/lactation may receive no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multi-center, post-market cosmetic evaluation evaluating Ariessence Pure PDGF+ as a leave-on solution applied to the full face after ablative laser treatment. The study compares tolerability and cosmetic outcomes between Ariessence and Aquaphor using subject diaries, investigator assessments, and standardized photos on days 3, 7, and 14. Participants are adults ages 40-65 with mid-to-severe aging concerns (Glogau III-IV) and Fitzpatrick II-IV, who are non-smokers and suitable for ablative laser. Excluded are those with active skin disease, recent facial procedures, pregnancy, implants, or history of keloids. Lead sponsor is Lynch Regenerative Medicine and participating sites are in California and Tennessee.
Why it matters
Potential benefit: If successful, Ariessence could reduce post-procedure discomfort and improve early skin appearance after laser treatment.
How similar studies have gone: Post-procedure topical growth factor products have shown potential benefits in some cosmetic procedures, but this exact post-market evaluation is relatively novel in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria -:Adults 40-65 70 years * Glogau III-IV * Fitzpatrick II-IV. * Suitable for ablative laser * non-smoker ≥ 3 years * Willing to comply with post-procedure regimen * patient reported outcome documentation, and photo documentation. Exclusion Criteria: * Fitzpatrick I or \> IV, * recent facial procedures (\< 6 months) * active skin disease * pregnancy/lactation * implanted devices * history of keloids.
Where it's running
-
Laser & Skin Surgery Medical Group
Sacramento, California, United States Recruiting -
The Practice of Brian S. Biesman, MD
Nashville, Tennessee, United States Recruiting
Study contacts
- Study coordinator: Josh Arnold
- Email: clinicaltrials@purity-health.com
- Phone: 302-604-4532
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aquatic power training dosing strategies and creatine in older adults
This trial tests whether different aquatic power training dosing methods and creatine supplementation help improve function in community-dwelling adults aged 60 and older.
-
Intergenerational Interaction Program for Nursing Home Residents and Nursing Students
A 6-week program pairs nursing home residents with nursing students to see if weekly joint activities can increase joy and reduce loneliness for older adults and lessen ageism in students.
-
Supplemental Mobility for older adults in skilled nursing facilities
This pilot tests whether adding a mobility aide to support walking and transfers alongside regular rehab helps older adults in SNFs after hospitalization see more daily activity and safer mobility.
-
Smart Voice Platform to Support Quality of Life for Community-Living Older Adults
A smart voice platform is tested to see if it improves quality of life and healthy aging for older adults living in the community.
-
Digital STEADI: A home-based digital fall prevention program for older adults
A home-based digital program using AI-driven conversational agents tests if a guided fall-prevention exercise plan can reduce fall risk for older adults with mild cognitive impairment living independently.
-
Sex hormones, menopause, and exercise in aging women
This study tests how hormonal status and resistance training affect age-related muscle and nerve function in postmenopausal women.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.